Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN

Sonnet BioTherapeutics Holdings (SONN) Stock Price & Analysis

333 Followers

SONN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.91 - $9.37
Previous Close$1.06
Volume81.61K
Average Volume (3M)573.38K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.05M
Total Debt (Recent Filing)$255.99K
Price to Earnings (P/E)-0.2
Beta1.32
Next EarningsAug 15, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-6.82
Shares Outstanding7,934,156
R-Squared0.03
Standard Deviation0.20
10 Day Avg. Volume381,793
30 Day Avg. Volume573,376
Price to Book (P/B)-3.59
Price to Sales (P/S)41.97
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside549.85% Upside
Rating ConsensusModerate Buy
Alpha-0.10
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

SONN FAQ

What was Sonnet BioTherapeutics Holdings’s price range in the past 12 months?
Sonnet BioTherapeutics Holdings lowest stock price was $0.91 and its highest was $9.37 in the past 12 months.
    What is Sonnet BioTherapeutics Holdings’s market cap?
    Currently, no data Available
    When is Sonnet BioTherapeutics Holdings’s upcoming earnings report date?
    Sonnet BioTherapeutics Holdings’s upcoming earnings report date is Aug 15, 2022 which is 176 days ago.
      How were Sonnet BioTherapeutics Holdings’s earnings last quarter?
      Sonnet BioTherapeutics Holdings released its earnings results on May 10, 2022. The company reported -$1.96 earnings per share for the quarter, missing the consensus estimate of -$1.723 by -$0.237.
        Is Sonnet BioTherapeutics Holdings overvalued?
        According to Wall Street analysts Sonnet BioTherapeutics Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Sonnet BioTherapeutics Holdings pay dividends?
          Sonnet BioTherapeutics Holdings does not currently pay dividends.
          What is Sonnet BioTherapeutics Holdings’s EPS estimate?
          Sonnet BioTherapeutics Holdings’s EPS estimate is -$1.95.
            How many shares outstanding does Sonnet BioTherapeutics Holdings have?
            Sonnet BioTherapeutics Holdings has 7,934,156 shares outstanding.
              What happened to Sonnet BioTherapeutics Holdings’s price movement after its last earnings report?
              Sonnet BioTherapeutics Holdings reported an EPS of -$1.96 in its last earnings report, missing expectations of -$1.723. Following the earnings report the stock price went down -9.828%.
                Which hedge fund is a major shareholder of Sonnet BioTherapeutics Holdings?
                Currently, no hedge funds are holding shares in SONN

                ---

                Sonnet BioTherapeutics Holdings Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -76.10%
                12-Months-Change

                Fundamentals

                Return on Equity
                -301.42%
                Trailing 12-Months
                Asset Growth
                -79.89%
                Trailing 12-Months
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Sonnet BioTherapeutics Holdings

                Sonnet BioTherapeutics (NASDAQ:SONN) is a clinical-stage biotechnology company that is focused on the development of drugs for the treatment of cancer.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Allarity Therapeutics, Inc.
                CohBar
                Hillstream BioPharma, Inc.
                Salarius Pharmaceuticals
                Histogen

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis